Aclarion (ACON) Competitors $0.18 +0.00 (+0.51%) (As of 10:46 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends ACON vs. ATIP, KDLY, MGRX, ATPC, BGLC, VSEE, CMAX, NIVF, BACK, and GBNHFShould you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include ATI Physical Therapy (ATIP), Kindly MD (KDLY), Mangoceuticals (MGRX), Agape ATP (ATPC), BioNexus Gene Lab (BGLC), Vsee Health (VSEE), CareMax (CMAX), NewGenIvf Group (NIVF), IMAC (BACK), and Greenbrook TMS (GBNHF). These companies are all part of the "healthcare" industry. Aclarion vs. ATI Physical Therapy Kindly MD Mangoceuticals Agape ATP BioNexus Gene Lab Vsee Health CareMax NewGenIvf Group IMAC Greenbrook TMS Aclarion (NASDAQ:ACON) and ATI Physical Therapy (NYSE:ATIP) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, community ranking, dividends, risk, institutional ownership and earnings. Does the media favor ACON or ATIP? In the previous week, Aclarion had 2 more articles in the media than ATI Physical Therapy. MarketBeat recorded 2 mentions for Aclarion and 0 mentions for ATI Physical Therapy. Aclarion's average media sentiment score of 1.50 beat ATI Physical Therapy's score of 0.00 indicating that Aclarion is being referred to more favorably in the media. Company Overall Sentiment Aclarion Very Positive ATI Physical Therapy Neutral Is ACON or ATIP more profitable? ATI Physical Therapy has a net margin of -7.79% compared to Aclarion's net margin of -12,845.05%. ATI Physical Therapy's return on equity of 0.00% beat Aclarion's return on equity.Company Net Margins Return on Equity Return on Assets Aclarion-12,845.05% -422.87% -201.15% ATI Physical Therapy -7.79%N/A -3.87% Which has preferable valuation and earnings, ACON or ATIP? Aclarion has higher earnings, but lower revenue than ATI Physical Therapy. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$80K23.12-$4.91MN/AN/AATI Physical Therapy$699.02M0.01-$69.79M-$18.57-0.08 Which has more risk and volatility, ACON or ATIP? Aclarion has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Comparatively, ATI Physical Therapy has a beta of 0.42, meaning that its stock price is 58% less volatile than the S&P 500. Do analysts rate ACON or ATIP? Aclarion currently has a consensus price target of $1.50, suggesting a potential upside of 746.02%. Given Aclarion's stronger consensus rating and higher possible upside, research analysts plainly believe Aclarion is more favorable than ATI Physical Therapy.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00ATI Physical Therapy 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals hold more shares of ACON or ATIP? 7.5% of Aclarion shares are owned by institutional investors. Comparatively, 72.6% of ATI Physical Therapy shares are owned by institutional investors. 1.7% of Aclarion shares are owned by company insiders. Comparatively, 3.3% of ATI Physical Therapy shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the MarketBeat Community prefer ACON or ATIP? ATI Physical Therapy received 12 more outperform votes than Aclarion when rated by MarketBeat users. However, 100.00% of users gave Aclarion an outperform vote while only 36.59% of users gave ATI Physical Therapy an outperform vote. CompanyUnderperformOutperformAclarionOutperform Votes3100.00% Underperform VotesNo VotesATI Physical TherapyOutperform Votes1536.59% Underperform Votes2663.41% SummaryAclarion and ATI Physical Therapy tied by winning 8 of the 16 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACON vs. The Competition Export to ExcelMetricAclarionMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.85M$3.07B$5.08B$8.80BDividend YieldN/A11.18%5.02%4.07%P/E RatioN/A9.0391.2813.60Price / Sales23.12215.431,226.2187.40Price / CashN/A406.7839.4536.27Price / Book0.743.206.906.33Net Income-$4.91M-$32.86M$118.83M$225.93M7 Day Performance4.36%0.59%-1.92%-0.96%1 Month Performance-9.08%-0.23%-3.75%1.06%1 Year Performance-96.28%25.97%31.37%26.59% Aclarion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACONAclarion2.6062 of 5 stars$0.18+0.5%$1.50+746.0%-95.9%$1.85M$80,000.000.007News CoveragePositive NewsATIPATI Physical Therapy0.224 of 5 stars$1.56-1.9%N/A-78.2%$6.88M$699.02M0.005,600KDLYKindly MD0.1582 of 5 stars$1.05+15.4%N/AN/A$6.28MN/A0.00N/AGap UpMGRXMangoceuticals0.508 of 5 stars$2.41-2.4%N/A-98.1%$6.00M$730,000.000.003Gap DownATPCAgape ATP0.013 of 5 stars$1.48+2.8%N/A-92.4%$5.91M$1.43M0.0040BGLCBioNexus Gene LabN/A$0.29-3.3%N/A-22.6%$5.21M$9.77M0.0030VSEEVsee Health0.3541 of 5 stars$1.33+0.8%N/AN/A$4.79MN/A0.00N/ANews CoverageGap UpCMAXCareMax1.0108 of 5 stars$0.79+6.8%N/A-97.4%$3.02M$751.10M0.001,450NIVFNewGenIvf Group1.6259 of 5 stars$0.55-7.5%N/AN/A$2.05M$5.14M0.00N/ABACKIMACN/A$1.02-1.0%N/A-29.9%$1.17M$16.19M0.00180GBNHFGreenbrook TMSN/A$0.02flatN/AN/A$636,000.00$73.79M0.00430 Related Companies and Tools Related Companies ATI Physical Therapy Competitors Kindly MD Competitors Mangoceuticals Competitors Agape ATP Competitors BioNexus Gene Lab Competitors Vsee Health Competitors CareMax Competitors NewGenIvf Group Competitors IMAC Competitors Greenbrook TMS Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ACON) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.